Fig. 1
Overall survival (OS) and progression-free survival (PFS) of 215 patients with early-stage nasal-type extranodal natural killer/T-cell lymphoma (ENKTCL)
Fig. 1 | Chinese Journal of Cancer
Overall survival (OS) and progression-free survival (PFS) of 215 patients with early-stage nasal-type extranodal natural killer/T-cell lymphoma (ENKTCL)